Chromosomal instability confers intrinsic multidrug resistance

Area of Science:

• Oncology
• Genetics
• Cancer Biology

Background:

• Aneuploidy, a hallmark of many solid tumors, is associated with poor prognosis.
• Chromosomal instability (CIN) arising from aneuploidy may drive multidrug resistance and tumor relapse.
• Targeting tumor karyotypic complexity presents a promising therapeutic avenue.

Purpose of the Study:

• To identify therapeutic strategies targeting CIN colorectal cancer (CRC) cells.
• To investigate the relationship between CIN, ploidy, and multidrug resistance in CRC.
• To evaluate the prognostic significance of CIN in CRC patient outcomes.

Main Methods:

• Utilized a panel of CIN(+) and CIN(-) CRC cell lines.
• Treated cell lines with a library of kinase inhibitors.
• Performed meta-analysis of CRC patient outcomes following cytotoxic treatment.

Main Results:

• CIN(+) CRC cell lines exhibited intrinsic multidrug resistance, independent of mutation status or proliferation rate.
• Tetraploid cells with increased chromosomal heterogeneity showed reduced drug sensitivity.
• CIN(+) status predicted worse progression-free or disease-free survival in CRC patients.

Conclusions:

• CIN, rather than ploidy alone, is strongly associated with multidrug resistance in CRC.
• Tumor CIN status should be considered in clinical trials to refine treatment strategies and minimize confounding effects on drug sensitivity.